Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Miscellaneous and site unspecified neoplasms malignant and unspecified
ADR ID BADD_A02790
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.16      Miscellaneous and site unspecified neoplasms malignant and unspecified
Description Not Available
MedDRA Code 10027655
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02208Thyrotropin alfa--
BADD_D02210Tiagabine--
BADD_D02211Tiagabine hydrochloride--
BADD_D02213Tibolone--
BADD_D02214Ticagrelor--
BADD_D02217Tigecycline0.000049%
BADD_D02222Tinzaparin sodium--
BADD_D02227Tipranavir disodium--
BADD_D02230Tizanidine--
BADD_D02231Tizanidine hydrochloride--
BADD_D02234Tocilizumab--
BADD_D02236Tofacitinib0.026956%
BADD_D02237Tofacitinib citrate--
BADD_D02241Tolcapone--
BADD_D02244Tolterodine0.000226%
BADD_D02246Tolvaptan0.000698%
BADD_D02247Topiramate--
BADD_D02248Topotecan0.000974%
BADD_D02249Topotecan hydrochloride--
BADD_D02252Tositumomab--
BADD_D02254Tramadol--
BADD_D02257Trametinib0.007757%
BADD_D02258Trametinib dimethyl sulfoxide--
BADD_D02265Travoprost0.000367%
BADD_D02266Trazodone--
BADD_D02270Tretinoin--
BADD_D02299Trisequens--
BADD_D02312Ulipristal--
BADD_D02319Urofollitropin--
BADD_D02321Ursodiol--
The 14th Page    First    Pre   14 15 16 17 18    Next   Last    Total 18 Pages